Reblozyl clinical trials

Luspatercept in Patients Affected With Rare Inherited Anemias

This study is looking into a new treatment called Luspatercept for adults with rare inherited blood conditions that cause anaemia. It's a Phase 2 trial, meaning it's still in earlier stages of testing, to see how well the medicine works and if it's safe.